Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It" ALT"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who…
Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017)
Life Sciences Jobs ... Source: BioSpace
Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free" ALT"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple…
7 Biotechs and Pharmas That Have the Potential to Double (or More)
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"7 Biotechs and Pharmas That Have the Potential to Double (or More)" ALT"7 Biotechs and Pharmas That Have the Potential to Double (or More)"June 1, 2017By Mark Terry,…
Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-novartis-joseph-jimenez2.jpg" NAME"Novartis AG Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston" ALT"Novartis AG Lays Out R&D Game Plan at Meet and Greet With…
- Go to the previous page
- 1
- …
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- …
- 288
- Go to the next page